+Vote!
Seeking Alpha (Free subscription) | 6 hours ago
Mike Huckman submits: In the current monster-sized issue of Vogue , my producer, Ruth, while killing time on the Delta shuttle on our way from New York to Boston for a shoot this week, uncovered a blogworthy story buried in the hundreds and hundreds and hundreds of pages of fashion ads. It represents a whole new idea in the world of direct-to-consumer [DTC] drug advertising. Merck (MRK) has recently...
+Vote!
Day on Torts (Free subscription) | 8 hours ago
It doesn't necessarily represent the standard of care. It is the place to begin, not end, your medical research. But it is a great place to start. Merck Manual...
+Vote!
Pharmalot (Free subscription) | yesterday
First, there was the Gardasil beach towel, an attractive terry velour model that advertised to beachgoers that you’re free of a sexually transmitted disease. A nifty way to tout the advantages of the HPV vaccine. Now, Merck is trying a new way to grab the attention of teenagers and younger adult women with a specially created [...]
+Vote!
New York Times (Free subscription) | yesterday
To the Editor: Related (August 20, 2008) Re “Drug Makers’ Push Leads to Vaccines’ Fast Rise” (front page, Aug. 20):Gardasil, Merck’s vaccine against the human papillomavirus, or HPV, has received nearly universal support from medical associations, regulatory bodies and policy-making groups because the vaccine is highly effective to help prevent cervical disease, including cancer. Indeed, “A Necessary...
+Vote!
Market Wire - Investment Opinion (Free subscription) | 27/08/2008
LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Bristol-Myers Squibb Company (NYSE: BMY), Merck & Co. Inc....
+Vote!
MSNBC.com (Free subscription) | 19 hours ago
New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers said on Thursday.
+Vote!
Baxojayz - Centricity (Free subscription) | yesterday
Nashville rockers SafetySuit have released their debut music video for “Someone Like You.” The Zach Merck (Shadows Fall, Blue October) directed video was shot in Venice Beach, CA and features various stories told using a split screen and a rocking performance on the beach. The video can be seen from the band’s new widget that also includes webisodes from the road. “Someone Like You” video: http://universalmotown.com/releases/?plid=1457712391&v=1729330258&aid=0...
+Vote!
Life Science World (Free subscription) | yesterday
[NEWS] VIENNA, Austria, Aug. 28 /PRNewswire/ — Intercell AG (VSE: ICLL) today announced that its collaborator Merck & Co., Inc. has initiated a Phase II clinical trial of V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infections. This randomized double blind, placebo controlled study aims to evaluate the safety and immunogenicity of the vaccine candidate in...
+Vote!
Health Care Renewal (Free subscription) | yesterday
Available in 3 parts on the Clinical Psychology and Psychiatry Blog ( here , here , and here ), and in one part on PharmaLot, is a video apparently used for training Merck pharmaceutical sales representatives to sell Vioxx (rofecoxib) to doubtful physicians. The strategy seemed to be to use flash and bluster to avoid dealing with concerns that Vioxx was no more effective a pain reliever than generic...
+Vote!
Pharmalot (Free subscription) | yesterday
Maybe not when it comes to Vytorin. You may recall that preliminary results of a study called SEAS were released last month and unexpectedly revealed a crop of cancer-related deaths, which Merck and Schering-Plough labeled an anomaly. However, the explanation appears not to have convinced everyone that the drug, which combines Zetia and Zocor, is [...]
+Vote!
Pharmalot (Free subscription) | 27/08/2008
…more accustomed to backing Republican candidates for president. As the Democratic Convention builds to its unsurprising crescendo, a few drugmakers have tried to generate some political capital behind the scenes. For instance, Merck, Amgen, Pfizer, AstraZeneca, Novartis, Mylan Labs, Abbott Labs and Lilly all signed up as official sponsors. And as FDA Legislative Watch notes, the [...]
+Vote!
BMI Headlines (Free subscription) | 27/08/2008
Two years after broadcast networks, newspapers heralded Gardasil 'breakthrough,' Merck under attack for marketing its product.
+Vote!
PharmaGossip (Free subscription) | 27/08/2008
The European Medicine Agency’s (EMEA) Paediatric Committee has decided not to recommend use of Vytorin and a related treatment that Merck submitted for treating high cholesterol in children. The cholesterol drugs “do not represent a significant therapeutic benefit over existing treatments,” the EMEA says in a statement. The decision is the latest setback on Vytorin (ezetimibe/simvastatin) for Merck,...
